Liz Homans - Lyell
bm-navigation: bm-t3-home-navigation
bm-pageheader: bm-t3-pageheader

Liz Homans

Chief Executive Officer

Liz Homans

Liz-HomansLiz joined Lyell with over 30 years of strategy, product development, and commercialization experience. For the last two years she has been the President of Lyell and the operational lead as Lyell grew in size, scope and ambition.

Prior to Lyell Liz worked at Genentech for just over a decade in multiple divisions including global product development, regulatory operations, and US sales and marketing. She spent the bulk of her Genentech career leading large complex oncology development programs from PhII through completion of pivotal studies submission, approval, and launch. She is also an experienced commercial leader having led the US Xolair franchise through two years of double-digit growth. She completed her tenure at Genentech by managing the US Breast cancer franchise. Liz also led global regulatory operations for Roche.

Prior to Genentech Liz spent four years at Jazz Pharmaceuticals where she built the project leadership and portfolio strategy team. Liz also has a decade of business strategy consulting experience with Booz Allen and Hamilton and Analysis Group (formerly Integral) working with pharmaceutical, energy, and chemical companies.

Liz has an MBA from Columbia University in New York and a BA in German and Economics from Bates University.